BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hao DL, Xie R, De GJ, Yi H, Zang C, Yang MY, Liu L, Ma H, Cai WY, Zhao QH, Sui F, Chen YJ. pH-Responsive Artesunate Polymer Prodrugs with Enhanced Ablation Effect on Rodent Xenograft Colon Cancer. Int J Nanomedicine 2020;15:1771-86. [PMID: 32214810 DOI: 10.2147/IJN.S242032] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Jiaying Y, Bo S, Xiaolu W, Yanyan Z, Hongjie W, Nan S, Bo G, Linna W, Yan Z, Wenya G, Keke L, Shan J, Chuan L, Yu Z, Qinghe Z, Haiyu Z. Arenobufagin-loaded PEG-PLA nanoparticles for reducing toxicity and enhancing cancer therapy. Drug Deliv 2023;30:2177362. [PMID: 36772846 DOI: 10.1080/10717544.2023.2177362] [Reference Citation Analysis]
2 Wei J, Zhu L, Lu Q, Li G, Zhou Y, Yang Y, Zhang L. Recent progress and applications of poly(beta amino esters)-based biomaterials. J Control Release 2023;354:337-53. [PMID: 36623697 DOI: 10.1016/j.jconrel.2023.01.002] [Reference Citation Analysis]
3 Li G, Ling M, Yu K, Yang W, Liu Q, He L, Cai X, Zhong M, Mai Z, Sun R, Xiao Y, Yu Z, Wang X. Synergetic delivery of artesunate and isosorbide 5-mononitrate with reduction-sensitive polymer nanoparticles for ovarian cancer chemotherapy. J Nanobiotechnol 2022;20:471. [DOI: 10.1186/s12951-022-01676-3] [Reference Citation Analysis]
4 Ju J, Wu Y, He W, Zhan L, Yin X, Zhang J, Zhang Y, Qiu L, Muhammad P, Reis RL, Li C. Nanocarriers for Active Ingredients of Chinese Medicine (AIFCM) Used in Gastrointestinal Cancer Therapy. j biomed nanotechnol 2022;18:2279-2314. [DOI: 10.1166/jbn.2022.3446] [Reference Citation Analysis]
5 Hao D, Wang Y, Yang J, Xie R, Jia L, Cheng J, Ma H, Tian J, Guo S, Liu T, Sui F, Zhao Y, Chen Y, Zhao Q. The Alleviation of LPS-Induced Murine Acute Lung Injury by GSH-Mediated PEGylated Artesunate Prodrugs. Front Pharmacol 2022;13:860492. [DOI: 10.3389/fphar.2022.860492] [Reference Citation Analysis]
6 Farmanpour-Kalalagh K, Beyraghdar Kashkooli A, Babaei A, Rezaei A, van der Krol AR. Artemisinins in Combating Viral Infections Like SARS-CoV-2, Inflammation and Cancers and Options to Meet Increased Global Demand. Front Plant Sci 2022;13:780257. [PMID: 35197994 DOI: 10.3389/fpls.2022.780257] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
7 Beyraghdar Kashkooli A, Farmanpour-kalalagh K, Babaei A. Yeast Synthetic Biology for Production of Artemisinin as an Antimalarial Drug. Synthetic Biology of Yeasts 2022. [DOI: 10.1007/978-3-030-89680-5_6] [Reference Citation Analysis]
8 Khatun S, Bonala S, Pogu SV, Rengan AK. Functional Biomaterials: Drug Delivery and Biomedical Applications Polymeric Micelle in Drug Delivery Applications. Functional Biomaterials 2022. [DOI: 10.1007/978-981-16-7152-4_1] [Reference Citation Analysis]
9 Tang L, Li J, Zhao Q, Pan T, Zhong H, Wang W. Advanced and Innovative Nano-Systems for Anticancer Targeted Drug Delivery. Pharmaceutics 2021;13:1151. [PMID: 34452113 DOI: 10.3390/pharmaceutics13081151] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 12.0] [Reference Citation Analysis]
10 Jin Y, Wang Y, Liu X, Zhou J, Wang X, Feng H, Liu H. Synergistic Combination Chemotherapy of Lung Cancer: Cisplatin and Doxorubicin Conjugated Prodrug Loaded, Glutathione and pH Sensitive Nanocarriers. Drug Des Devel Ther 2020;14:5205-15. [PMID: 33268983 DOI: 10.2147/DDDT.S260253] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
11 Xu C, Zhang H, Mu L, Yang X. Artemisinins as Anticancer Drugs: Novel Therapeutic Approaches, Molecular Mechanisms, and Clinical Trials. Front Pharmacol 2020;11:529881. [PMID: 33117153 DOI: 10.3389/fphar.2020.529881] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]